Related Experiment Video

Updated: Jun 2, 2026

Pseudomonas aeruginosa Induced Lung Injury Model
07:24

Pseudomonas aeruginosa Induced Lung Injury Model

Published on: October 29, 2014

Hemolytic phospholipase C inhibition protects lung function during Pseudomonas aeruginosa infection

Matthew J Wargo1, Maegan J Gross, Sathish Rajamani

  • 1Department of Microbiology and Molecular Genetics, University of Vermont College of Medicine, Burlington, VT 05405, USA. Matthew.Wargo@med.uvm.edu

American Journal of Respiratory and Critical Care Medicine
|May 13, 2011
PubMed
Abstract

Insights

Pseudomonas aeruginosa PlcHR damages lung function by impairing surfactant. The drug miltefosine inhibits PlcHR, protecting lung function during P. aeruginosa infection.

Area of Science:

  • Microbiology
  • Pulmonary Physiology
  • Pharmacology

Background:

  • Pseudomonas aeruginosa is an opportunistic pathogen causing severe lung infections, especially in cystic fibrosis patients.
  • P. aeruginosa virulence factors significantly contribute to lung function decline, increasing morbidity and mortality.
  • Understanding specific bacterial factors and their impact on host physiology is crucial for developing effective treatments.

Purpose of the Study:

  • To elucidate the direct role of the phospholipase C/sphingomyelinase, PlcHR, in altering lung physiology during P. aeruginosa infection.
  • To evaluate miltefosine as a potential therapeutic agent to protect lung function against PlcHR-mediated damage.

Main Methods:

  • Mice were infected with wild-type or ΔplcHR P. aeruginosa strains.
  • Lung function was assessed using computer-controlled mechanical ventilation.
  • Miltefosine was administered intraperitoneally post-infection to evaluate its protective effects.

Main Results:

  • P. aeruginosa wild-type infection severely impaired lung function, while the ΔplcHR strain caused significantly less damage.
  • PlcHR was shown to reduce pulmonary surfactant function in bronchoalveolar lavage fluid.
  • Miltefosine inhibited PlcHR's lipid cleavage activity in vitro and protected lung function in vivo.

Conclusions:

  • This study directly links the P. aeruginosa virulence factor PlcHR to impaired lung function.
  • Miltefosine effectively protects lung function by inhibiting PlcHR-dependent surfactant dysfunction.

More Related Videos

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice15:43

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa07:27

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Published on: July 12, 2018

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation